Case Study

Seamless Transition, Measurable Results

How Worldwide Flex Stabilized a Biotech Sponsor’s Data Management and Biostatistics Functions

Read more

A biotech sponsor engaged an academic CRO (ACRO) to manage data management and biostatistics for an active clinical study, but persistent data quality issues and a deteriorating clean-up cadence placed the program’s integrity at risk. Recognizing the imperative to protect the integrity of study data without disrupting program momentum, the sponsor made a decisive decision to transition these critical functions to Worldwide Flex. Worldwide demonstrated the operational agility that defines the Flex model, and the depth of expertise required to remediate a compromised data environment without losing a step. Transition activities encompassed coordinating the transfer of essential systems and study materials from the ACRO and assuming full programming and administrative rights for the EDC platform. This also involved establishing rigorous access controls and designing and deploying a robust suite of edit checks and manual data review protocols.

Read the full case study to learn how Worldwide Flex, through rapid mobilization, disciplined data remediation, and a deeply collaborative partnership model, stabilized an at-risk clinical program and achieved an interim database lock within the first year.

Want to learn more about Worldwide Clinical Trials?